Results 111 to 120 of about 14,514 (174)

Pathological characteristics of coxsackievirus A14 in neonatal mice model. [PDF]

Virol J
Yu L, Li J, Lu H, Liu Y, Guo Q, Zhou L, Cong R, Sun T, Zhu S, Yang Q, Ji T, Zhang Y, Yan D.   +12 more
europepmc   +1 more source

Enteroviral Meningitis-Associated Respiratory Deterioration in a Neonate Treated With High-Flow Nasal Cannula Therapy. [PDF]

Cureus
Sato R, Ohnishi T, Tomita M, Nakazawa M, Kamimaki I.   +4 more
europepmc   +1 more source

Full-genome analysis of emerging Coxsackievirus B4 genotype D strains associated with herpangina in eastern China. [PDF]

Microb Genom
Hu X, Sun Y, Xing B, Hu L, Liang Z, Fu J, Liang Y, Chen Y, Li Y, Chen L, Wang L, Wang W, Wang S, Lu Y.   +13 more
europepmc   +1 more source

Editorial: Immunological regulation to enteroviruses and respiratory viruses: infection and vaccination responses. [PDF]

Front Immunol
Zheng H.
europepmc   +1 more source

Myxovirus resistance protein A to differentiate between viral and non-viral respiratory infections in adults: a prospective study. [PDF]

Emerg Microbes Infect
Yan M, Wang N, Yang L, Zhang X, Zhang Y, Xuan W, Zhang X, Liu G, Wang H, Qing Y, Wang Y, Cao B.   +11 more
europepmc   +1 more source

Coxsackievirus B3 Cleaves INTS10 Through 3C Protease to Facilitate Its Replication. [PDF]

Int J Mol Sci
Yuan L, Lin L, Bi C, Niu X, Chen Y, Fei Y, Wang G, Wang H, Wang Y, Zhao W, Zhong Z, Lin L.   +11 more
europepmc   +1 more source

Does Coxsackievirus B3 Require Autophagosome Formation for Replication? Evidence for an Autophagosome-Independent Mechanism: Insights into Its Limited Potential as a Therapeutic Target. [PDF]

Pharmaceuticals (Basel)
Ga YJ, Yeh JY.
europepmc   +1 more source

Oral Immunization with the C488A Live-Attenuated Mutant of Coxsackievirus B4E2 (CVB4E2) Induces Potent Immune Response and Protects Balb/c Mice Against Lethal Infection. [PDF]

Viruses
Gharbi J, Hadj Hassine I, Hassine M, Al-Bashir A, Al-Chahri R, Al-Yami A, Al-Malki M, Chatti N, Hober D, M'hadheb MB.   +9 more
europepmc   +1 more source

Oncolytic Virotherapy and Immunogenic Cell Death: Mechanisms, Platforms, and Clinical Translation. [PDF]

Viruses
Inoue H.
europepmc   +1 more source

The Recombinant Viral Capsid Protein rVP1 Induces Protective Immunity Against Coxsackievirus B3 (CVB3) Lethal Challenges in Balb/c Mouse Model. [PDF]

Vaccines (Basel)
Ben M'hadheb M, Hassine IH, Almalki MA, Hassine M, Gharbi J.   +4 more
europepmc   +1 more source